Search - tctmd.com

Displaying 81 - 100 of 275

Sort: Relevancy | Date

News Daily News

Polymer-Free DES Hold No Long-term Advantage: ISAR-TEST-5

Michael O'Riordan

July 07, 2020

News Industry News

CeloNova Announces Enrollment Completion of World’s First Randomized Control, 14-Day DAPT Trial

June 01, 2020

News Daily News

Functionally Significant Nonculprit Lesions Pose Risk in STEMI Patients

Michael O'Riordan

April 21, 2020

News Daily News

Smoker’s Paradox Debunked: Post-STEMI Outcomes Worse in Cigarette Smokers

Michael O'Riordan

April 15, 2020

News Daily News

Potent Antithrombotic Therapy Cuts Spontaneous MI After PCI for ACS

Yael L. Maxwell

March 10, 2020

News Daily News CRT 2020

Meta-analysis Shows Similar 5-Year Mortality for PCI, CABG in Left Main Disease

Michael O'Riordan

March 04, 2020

News Features

Trial by Twitter: How a 280-Character Count Is Reshaping Cardiology

Michael O'Riordan

March 03, 2020

News Conference News CRT 2020

Good Coronary Collateral Circulation? Better LVEF and Survival After STEMI

Michael O'Riordan

February 24, 2020

News Conference News CRT 2020

Meta-analysis Upholds Complete PCI in STEMI, as Thoughts Turn to Timing, Costs

Michael O'Riordan

February 24, 2020

News Conference News LINC 2020

Lutonix BTK Studies: Below-the-Knee Challenges Linger

L.A. McKeown

January 29, 2020

News Daily News

No Fewer MACE With Ticagrelor vs Clopidogrel in ACS Patients After PCI: Registry

Todd Neale

January 15, 2020

News Daily News

EACTS Offers to Help to Resolve EXCEL Controversy, as CRF Launches Review

Michael O'Riordan

January 08, 2020

News Daily News

EACTS Calls for Independent Left Main CAD Evidence Review, Urges ESC Input

Shelley Wood

December 20, 2019

News Daily News

CvLPRIT: Long-term Reduction in Death/MI With Complete Revascularization

Michael O'Riordan

December 20, 2019

News Features

Year in Review: ISCHEMIA Tops Coronary News in 2019 but Other Trials Shine, Too

Michael O'Riordan

December 09, 2019

News Conference News AHA 2019

ISCHEMIA-CKD: Routine Invasive Approach No Help in CKD Patients With Stable CAD

Todd Neale

November 16, 2019

News Conference News

Former EXCEL Investigator Alleges Trial Manipulation, Prompting Vehement Denials

Michael O'Riordan

October 07, 2019

News Conference News TCT 2019

New COMPLETE Data Affirm Benefit of Nonculprit PCI in STEMI Regardless of Timing

Todd Neale

September 28, 2019

News Conference News TCT 2019

‘Spooky’ Signal Still Haunts Paclitaxel DCBs in PAD, but Updated Analysis Reassures

L.A. McKeown

September 28, 2019

News Industry News

Intact Vascular Announces Positive One-Year Data from TOBA III Clinical Trial

September 27, 2019

Advertisement

Polymer-Free DES Hold No Long-term Advantage: ISAR-TEST-5

CeloNova Announces Enrollment Completion of World’s First Randomized Control, 14-Day DAPT Trial

Functionally Significant Nonculprit Lesions Pose Risk in STEMI Patients

Smoker’s Paradox Debunked: Post-STEMI Outcomes Worse in Cigarette Smokers

Potent Antithrombotic Therapy Cuts Spontaneous MI After PCI for ACS

Meta-analysis Shows Similar 5-Year Mortality for PCI, CABG in Left Main Disease

Trial by Twitter: How a 280-Character Count Is Reshaping Cardiology

Good Coronary Collateral Circulation? Better LVEF and Survival After STEMI

Meta-analysis Upholds Complete PCI in STEMI, as Thoughts Turn to Timing, Costs

Lutonix BTK Studies: Below-the-Knee Challenges Linger

No Fewer MACE With Ticagrelor vs Clopidogrel in ACS Patients After PCI: Registry

EACTS Offers to Help to Resolve EXCEL Controversy, as CRF Launches Review

EACTS Calls for Independent Left Main CAD Evidence Review, Urges ESC Input

CvLPRIT: Long-term Reduction in Death/MI With Complete Revascularization

Year in Review: ISCHEMIA Tops Coronary News in 2019 but Other Trials Shine, Too

ISCHEMIA-CKD: Routine Invasive Approach No Help in CKD Patients With Stable CAD

Former EXCEL Investigator Alleges Trial Manipulation, Prompting Vehement Denials

New COMPLETE Data Affirm Benefit of Nonculprit PCI in STEMI Regardless of Timing

‘Spooky’ Signal Still Haunts Paclitaxel DCBs in PAD, but Updated Analysis Reassures

Intact Vascular Announces Positive One-Year Data from TOBA III Clinical Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content